Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 May 25;257(10):5900-9.

Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells

E M Avila, G Holdsworth, N Sasaki, R L Jackson, J A Harmony
  • PMID: 7068619
Free article

Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells

E M Avila et al. J Biol Chem. .
Free article

Abstract

Plasma lipoproteins with hydrated densities less than 1.063 g/ml, very low density, intermediate density, and low density lipoproteins, suppress mitogen-activated inductive biochemical events in lymphocytes. The ability of these lipoproteins to inhibit phytohemagglutinin (PHA)-enhanced incorporation of 32P into lymphocyte phospholipids correlates directly with the amount of associated apoprotein E (apo-E). Apo-E purified from the very low density lipoproteins of subjects with Types III, IV, and V hyperlipoproteinemia also inhibits PHA-induced 32P-phospholipid formation. With all of the apo-E preparations, 50% suppression occurs at approximately 2-4 microgram/ml and 100% suppression at 4-10 microgram/ml. Moreover, delipidated apo-E is an inhibitory as apo-E complexed with dimyristoyl phosphatidylcholine or with sphingomyelin. Other apoproteins, apo-AI, -AII, -CI, and -CIII, do not inhibit PHA-activated phospholipid turnover, indicating that suppression is due to a specific structural feature of apo-E. Suppression by apo-E is not due to a shift in the optimum concentration of PHA, nor is it the result of competition with PHA for mitogen receptors at the cell surface. These data, taken together with the results of previous studies (Hui, D. Y., and Harmony, J. A. K. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 4764-4768; Hui, D. Y., Harmony, J. A. K. (1980) J. Biol. Chem. 255, 11775-11781), indicate that lipoprotein-associated apo-E serves as a recognition determinant for lymphocyte surface receptors and as a suppressive lipoprotein constituent.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

LinkOut - more resources